No Detail Found!

Stability Studies of Cefuroxime in Peritoneal Dialysis Solution by Using the HPLC Method

Author(s)
Nosheen Tabassum Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan; Tehsil Head Quarter (THQ) Hospital Chak Jhumra, Faisalabad, Punjab, Pakistan.
Noor ul Amin Mohsin Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan.
Humna Akram Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan.
Muhammad Shan Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan.
Abstract
Summary: Peritoneal dialysis is a technique for blood purification and is used in chronic kidney disease. Peritonitis is a major problem linked to peritoneal dialysis which limits its utilization. Cephalosporins are extensively used for the treatment of peritoneal dialysis-related peritonitis. Cefuroxime is the second-generation cephalosporin that is used for the prevention and cure of peritonitis. The stability of cefuroxime in peritoneal dialysis solution was investigated after storage at different temperatures. Cefuroxime in different concentrations (250 mg, 750 mg and 1.5 g) was injected into the bags of peritoneal dialysis solution which were stored at 4 oC, 25 oC, and 40 oC. Samples were taken at regular intervals and evaluated by a validated HPLC method. Cefuroxime remained stable for fourteen days at 4 °C and the pattern of stability was the same for all concentrations of cefuroxime. At 25 °C, cefuroxime remained stable for 24 hours in isotonic and hypertonic PD solutions and maintained more than 90% of its initial concentrations. At 40 °C, cefuroxime remained stable for 6.7 and 6.0 hours in isotonic and hypertonic PD solutions respectively. The degradation of cefuroxime was higher in hypertonic solutions as compared to isotonic solutions.
Publication Details
Page(s) 462-473
Published Journal: Journal of Chemical Society of Pakistan, Volume: 46, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Temperature, HPLC, concentration, Peritonitis, Peritoneal dialysis solution
References
Mathers C.,Mascarenhas M. .2009 .Global health risks: mortality and burden of disease attributable to selected major risks. , : .
Kovesdy C.P. .2022 .. Epidemiology of chronic kidney disease: an update 2022, Kid. Int. Suppl., 12 : 7-11.
Liu F.X.,Gao X.,Chuengsaman P.,Pecoits-Filho R.,Yu A. .2015 .A global overview of the impact of peritoneal dialysis first or favored policies: an opinion, Perit. , 35 : 406-420.
M.C.C. Andreoli C.,Totoli C. .2020 .. Rev. Assoc. Med, 66 : s37-s44.
Saran R.,Robinson B.,Abbott K.C.,Agodoa L.Y.,Albertus P.,Ayanian J.,Balkrishnan R.,Bragg-Gresham J.,Cao J.,Chen J.L.,Cope E.,Dharmarajan S.,Dietrich X.,Eckard A.,Eggers P.W.,Gaber C.,Gillen D.,Gipson D.,Gu H.,Hailpern S.M.,Hall Y.N.,He K.,Hebert H.,Helmuth M.,Herman W.,Heung M.,Hutton D.,Jacobsen S.J.,Ji N.,Jin Y.,KalantarZadeh K.,Katz R.,Kovesdy C.P.,Kurtz V.,Lavalee D.,Li Y.,Lu Y.,McCullough K.,Molnar M.Z.,Montez-Rath M.,Morgenstern H.,Mu Q.,Mukhopadhyay P.,Nallamothu B.,Nguyen D.V.,Norris K.C.,A.M. O'Hare Y.,Obi J.,Pearson R.,Pisoni B.,Plattner F.K.,Port P.,Potukuchi P.,Rao K.,Ratkowiak V.,Ravel D.,Ray C.M.,Rhee D.E.,Schaubel D.T.,Selewski S.,Shaw J.,Shi M.,Shieu J.J.,Sim P.,Song M.,Soohoo D.,Steffick M.K.,Tamura F.,Tentori A.,Tilea L.,Tong M.,Turf D.,Wang M.,Wang K.,Woodside A.,Wyncott X.,Xin W.,Zang L.,Zepel S.,Zhang R.A.,Hirth V.,Shahinian V. .2017 .. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States, Am. J. Kidney Dis, 69 : A7.
Cullis B.,Abdelraheem M.,Abrahams G.,Balbi A.,Cruz D.N.,Frishberg Y.,Koch V.,McCulloch M.,Numanoglu A.,Nourse P. .2014 .Peritoneal dialysis for acute kidney injury. Perit. Dial. Int., 34 : 494-517.
P.K.T. Li W.,Lu S.K.,Mak N.,Boudville X.,Yu X.,M.J. Wu X.,Chan B.L.,Goh N.,Tian N. .2022 .Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact. Nephrology, 27 : 787-794.
K.T. Mills Y.,Xu W.,Zhang J.D.,Bundy T.N.,Kelly J.,Chen J.,He J. .2015 .A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010, Kidney Int. , 88 : 950-957.
Qayyum A.,Kid Pak. J. .2020 .Opinion: Peritoneal Dialysis In Pakistan: An Insider's View. State of Affairs and Planning?,. , 4 : .
C. Voinescu R.,Khanna R. .2002 .. Int. J. Artif. Organs., 25 : 249-260.
Tolonen M.,Ball C.,Kirkpatrick A. .2021 .Secondary peritonitis and intra-abdominal sepsis: an increasingly global disease in search of better systemic therapies. Scand. J. Surg., 110 : 139-149.
.2018 .Peritoneal dialysis-related peritonitis: challenges and solutions. Int. J. Nephrol. Renovasc. Dis., 11 : 173-186.
P.K.-T. Li C.C.,Szeto B.,Piraino S.,Fan A.E.,Figueiredo D.N.,Fish Y.- L.,Kim Y.- L. .2016 .ISPD peritonitis recommendations: 2016 update on prevention and treatment, Perit. , 36 : 481-508.
J.R. Ghali ,K.M. Bannister F.G.,Brown F.G.,Rosman K.J.,Wiggins D.W.,Johnson S.P.,McDonald S.P. .2011 .Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit. Dial. Int., 31 : 651-662.
Dahbour J.,Gibbs C.,Coletta J.,Hummell M.,Al-Sarie N.P.,Kahlon B.,Akpunonu B. .2020 .Peritoneal dialysis zoonotic bacterial peritonitis with Staphylococcus pseudintermedius. Case Rep. Nephrol. Dial., 10 : 65-70.
Mehrotra R.,Devuyst O.,Davies S.J.,Johnson D.W. .2016 .The current state of peritoneal dialysis. J. Am. Soc. Nephrol., 27 : 3238-3252.
Briggs V.,Davies S. .2019 .International variations in peritoneal dialysis utilization and implications for practice. Am. J. Kidney Dis, 74 : 101-110.
Brown E.A. .2020 .Increasing peritoneal dialysis use in response to the COVID-19 pandemic: will it go viral?. J. Am. Soc. Nephrol., 31, : 1928-1930.
Piraino B.,Bailie G.R.,Bernardini J.,Boeschoten E.,Gupta A.,Holmes C.,Kuijper E.J.,P.K.-T. Li W.-C.,Lye S.,Mujais S. .2005 .Peritoneal dialysis-related infections recommendations: 2005 update. Perit. Dial. Int., 25 : 107-131.
Tartaglione R.E.,Polk R.E. .1985 .Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Drug Intell. Clin. Pharm, 19 : 188-198.
Grotelueschen R.,Luetgehetmann M.,Erbes J.,Heidelmann L.M.,Grupp K.,Karstens K.,Ghadban T.,Reeh M.,Izbicki J.R.,Bachmann K. .2019 .Microbial findings, sensitivity and outcome in patients with postoperative peritonitis a retrospective cohort study. Int. Surg. J., 70 : 63-69.
Hui-Min Q.,Leung L. S.,Cheung S. W. .2001 .Is a first-or second-generation cephalosporin-based regime a suitable first-line antibiotic treatment for continuous ambulatory peritoneal dialysis peritonitis?. Hong Kong J. Nephrol., 3 : 15-20.
Corradini D.,Eksteen R.,Schoenmakers P.,Miller N. .1998 .. , : .
Hemström P.,Irgum K. .2006 .. J. Sep. Sci., 29 : 1784-1821.
Ranganathan D.,Naicker S.,Wallis S.C.,Lipman J.,Ratanjee S.K.,Roberts J.A. .2016 .Stability of antibiotics for intraperitoneal administration in extraneal 7.5% icodextrin peritoneal dialysis bags (STAB Study). Perit. Dial. Int., 36 : 421-426.
Mendes K.,Harmanjeet H.,Sedeeq M.,Modi A.,Wanandy T.,Zaidi S.T.R.,Ming L.C.,Castelino R.L.,Sud K.,Peterson G.M. .2018 .Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions. Perit. Dial. Int., 38 : 430-440.
Lian-Jie F.,Jia.Hui M.,Kai-Lli Z. .2012 .Content determination of cefuroxime in peritoneal dialysis solution by HPLC and compatible stability of the mixture. , 25 : 2378-2379.
C. Vercheval S.,Streel A.-C.,Servais M.,Fillet T. Van Hees .2018 .Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion. , 30 : 371-374.
Helin-Tanninen J.,Mustonen M.,Lehtonen O.,Korhonen O. .2018 .-012 Stability of cefuroxime 80 mg/ml solution in ready-to-administer polypropylene syringes. Eur. J. Hosp. Pharm., 25 : .
Ye Q.,Zhou L.,Fan Q.,Guo H.,Mao F.,Huang X.,Yu X.,Yang X. .2017 .The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients, BMC Nephrol. , 18 : 1-9.
So S.W.Y.,Chen L.,Woo A.Y.H.,Ng D.M.H.,Wong J.K.W.,K.M. Chow N.,Runnegar D.W.,Johnson D.W.,P.K.-T. Li D.W. .2022 .Stability and compatibility of antibiotics in peritoneal dialysis solutions, Clin. , 15 : 1071-1078.
0

Citations

0

Downloads

50

Views